Myoglobin and creatine kinase release in coronary care patients without acute myocardial infarction

Area of Science:

• Cardiology
• Biomarkers
• Clinical Diagnostics

Background:

• Acute myocardial infarction (AMI) diagnosis relies on clinical evaluation and cardiac biomarkers.
• Early detection of cardiac injury in non-AMI patients is crucial for risk stratification.

Purpose of the Study:

• To investigate the diagnostic and prognostic value of sequential serum myoglobin (MG) and creatine kinase (CK) measurements in coronary care patients initially evaluated as not having AMI.
• To identify distinct patterns of MG and CK release and their correlation with ECG changes and long-term cardiac events.

Main Methods:

• Studied 59 coronary care patients with symptom duration < 6 hours, excluding confirmed AMI.
• Performed sequential serum MG and CK measurements over 25 hours post-admission.
• Analyzed peak levels, timing of peaks, and correlated findings with ECG alterations and 2-year major coronary event incidence.

Main Results:

• Identified two groups: one with a serum MG peak followed by a CK peak (n=24) and one without.
• Patients with MG/CK peaks showed significantly higher rates of ECG alterations (84% vs. 43%).
• The overall patient group exhibited a 2-year major coronary event incidence similar to AMI patients, with a trend towards higher incidence in those with MG/CK release.

Conclusions:

• Sequential monitoring of serum MG and CK can identify coronary care patients at increased risk for adverse cardiac events, even without initial AMI diagnosis.
• The pattern of MG and CK release, particularly the sequence of peaks, is associated with more frequent ECG abnormalities.
• These biomarkers may aid in risk stratification and management of patients presenting with acute chest pain but initially negative for AMI.